type-1

Documents about type-1

• Assessing Plasma C-Peptide Levels and Their Relationship with Health-Related Quality of Life in Patients with Prediabetes and Type 1 and Type 2 Diabetes#229964Zenodo (CERN)
• The effect of the healthy lifestyle 'empowerment program' on care burden and adherence to health-promoting behaviours on mothers of children with type 1 diabetes.#136142PubMed
• Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1#322548HAL (France)
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes#329494ClinicalTrials.gov
• Rôle des canaux de type T dans les interneurones spinaux PKCγ dans un modèle de douleur neuropathique chez la souris#326202HAL (France)
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction#123654ClinicalTrials.gov
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake#136273ClinicalTrials.gov
• Turkish Version of The Diabetes Quality of Life Brief Clinical Inventory Validity and Reliability#217189ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#272322ClinicalTrials.gov
• Intelligent Control Strategies for DFIG-Based Wind Energy Systems: A Comparative Analysis of Type-1 Fuzzy, Interval Type-2 Fuzzy, and ANN Approaches#280503HAL (France)
• Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus#303688ClinicalTrials.gov
• A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes#175036ClinicalTrials.gov
• Multivariate statistical analysis on the kaolinite/chlorite ratios from 20 South Atlantic sediment cores#391345DataCite
• The effects of physical activity and nutrition interventions on glycated haemoglobin (HbA1c) in adolescents with type 1 diabetes mellitus: A systematic review with meta-analysis#406927ULRR
• Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)#15448HAL (France)
• Neural basis for mutant ATAXIN-1 induced respiratory dysfunction in mouse models of spinocerebellar ataxia type 1.#150228NCBI PubMed Central
• Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients#162380ClinicalTrials.gov
• Diabetes Technologies in Ultra-Endurance Type 1 Diabetes: Qualitative Study#164196HAL (France)
• Hippocampal Metabolism and Function in Patients With Type 1 Diabetes#184775ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®#195461ClinicalTrials.gov
• Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)#201722ClinicalTrials.gov
• Clinical Startup of the 670G Closed Loop Insulin Delivery System#238268ClinicalTrials.gov
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone#272289ClinicalTrials.gov
• Effect of Bile Acids on GLP-1 Secretion#272290ClinicalTrials.gov
• Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes#283193ClinicalTrials.gov
• Switch of AndroidAPS to Commercially Available AID Systems#290903ClinicalTrials.gov
• Device Use Reimagined Through Education And Mentorship#307398ClinicalTrials.gov
• Assessing the Impact of Control-IQ Technology#332665ClinicalTrials.gov
• Diabetes Adolescent and Family Group Therapy#349878ClinicalTrials.gov
• Diastolic Function in Myotonic Dystrophy Type 1#356555ClinicalTrials.gov
• Platelet PAR-1 Activation in Health and Diabetes#373729ClinicalTrials.gov
• The Salivary Microbiome in Children With Type 1 Diabetes Mellitus#383490ClinicalTrials.gov
• Evaluating GLP-1 Receptor Agonist in the Treatment of Type 2 Diabetes: A Comparison of Medication Efficacy and Cost#183365BYU ScholarsArchive
• Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes—the critical role of hypoglycaemia awareness: results from the SFDT1 study#14219HAL (France)
• Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)#153760HAL (France)
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#154871ClinicalTrials.gov
• Association between glycemic control, mental problems and nutrition in individuals with type 1 and type 2 diabetes mellitus in primary care settings.#219169NCBI PubMed Central
• The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus#249508ClinicalTrials.gov
• Caractérisation de la coagulopathie du syndrome aortique aigu#262253HAL (France)
• A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea#346820ClinicalTrials.gov
• A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes#369959ClinicalTrials.gov
• Microvascular Changes in OCT-angiography in Type 1 Diabetes Mellitus at the Onset of the Disease and After Optimization of Glycemic Control.#321645ClinicalTrials.gov
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy#158154ClinicalTrials.gov
• Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes#230367ClinicalTrials.gov
• Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice#241994IBISS
• Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice#241995IBISS
• Piloting an immersive virtual reality 3D self-management education experience for adults with Type 1 and Type 2 Diabetes Mellitus : a qualitative study#252025The Learning Edge
• Aging reshapes g/d T-cell immunity through a type I interferon-Foxo1 axis#294629HAL (France)
• Quality of Life among Diabetic Patients Type II in PHCs, Taif City, Saudi Arabia#433257HAL (France)
• Single Hormone Closed Loop Study With PDT Sensor#18806ClinicalTrials.gov